Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation

Allogeneic (allo) hematopoietic cell transplantation (HCT) is the only curative treatment option for patients suffering from chemotherapy-refractory or relapsed hematological malignancies. The occurrence of morbidity and mortality after allo-HCT is still high. This is partly correlated with the immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Linde, de Koning, Coco, Lindemans, Caroline, Nierkens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409323/
https://www.ncbi.nlm.nih.gov/pubmed/32698396
http://dx.doi.org/10.3390/cancers12071974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409323/
https://www.ncbi.nlm.nih.gov/pubmed/32698396
http://dx.doi.org/10.3390/cancers12071974

Ejemplares similares